Metagenomics for Ocular Inflammation
NCT06974162 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 36
Last updated 2025-11-20
Summary
The aim of this study is to apply a diagnostic test called 'metagenomic sequencing' to identify the involvement of potential infections in patients with ocular inflammation, where this hasn't been detected by currently available standard testing. For many people with ocular inflammation, no cause is ever found for their disease. In some cases, an infection or infectious trigger is suspected, but currently available tests are inadequate. Metagenomic sequencing can identify almost every globally known infection (bacteria, virus, fungi, parasites) in a sample. Therefore, it has the potential to identify an infection that has caused or triggered ocular inflammation, and as a consequence may help to identify specific treatments. It has the potential to improve our understanding of how to diagnose and treat people with this problem. This study will allow us to test the technique that has been previously optimised for brain infections, on ocular fluids. Participants will be 18 years of age or over and have active ocular inflammation which is suspected to be due to an infection, or an autoimmune process which has been triggered by an infection, but identification of this infection has not been possible using the investigations available as part of standard NHS care. Participants will be identified by the treating clinical team as requiring a sample of fluid from inside of the eye, and some of this fluid will be sent for metagenomic sequencing alongside standard testing. This study will be conducted at Moorfields Eye Hospital, London and will last for approximately a year. Participants will undergo additional non-invasive ocular imaging on the day of their clinic visit, but will not have to attend any additional research visits.
Conditions
- Uveitis
- Aqueous Humor
- Infection
Interventions
- DIAGNOSTIC_TEST
-
Metagenomic sequencing of aqueous humor
Metagenomic Sequencing on aqueous humor surplus to diagnostic requirements
- DIAGNOSTIC_TEST
-
Ocular Imaging
Ocular imaging with anterior segment OCT, laser flare photometry, confocal microscopy and colour fundus photography.
Sponsors & Collaborators
-
Great Ormond Street Hospital for Children NHS Foundation Trust
collaborator OTHER -
Moorfields Eye Hospital NHS Foundation Trust
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-12
- Primary Completion
- 2026-06-12
- Completion
- 2026-07-12
Countries
- United Kingdom
Study Locations
More Related Trials
-
Evaluation and Treatment of Patients With Inflammatory Eye Diseases
NCT00006188 ·Status: COMPLETED
-
Screening for NEI Clinical Studies
NCT00001734 ·Status: COMPLETED
-
The Cohort Study of Uveitis Patients
NCT05727540 ·Status: RECRUITING
-
Uveitis Gene-Expression Profiling
NCT00874471 ·Status: COMPLETED
-
Study of Intraocular Concentrations (Aqueous Humor, Vitreous Humor) of Antibiotics After Local and/or Systemic Administration in Endophthalmitis
NCT03968341 ·Status: UNKNOWN ·Phase: NA
-
UNICORNS: Uveitis in Childhood Prospective National Cohort Study
NCT05385757 ·Status: ACTIVE_NOT_RECRUITING
-
Analysis of Eye Tissue
NCT00001224 ·Status: COMPLETED
-
Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab
NCT00605943 ·Status: COMPLETED
-
A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants
NCT07218770 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy
NCT03022292 ·Status: COMPLETED ·Phase: PHASE4
-
Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,
NCT01526889 ·Status: COMPLETED ·Phase: PHASE2
-
Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
NCT02764697 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate
NCT01314417 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Uveitis/Intraocular Inflammatory Disease Biobank (iBank)
NCT02656381 ·Status: COMPLETED
-
Evaluation of Pain and Inflammation After Injection of Lucentis vs Eylea for Treatment of Wet Macular Degeneration
NCT01926977 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intravitreal Celecoxib for Chronic Uveitis
NCT02131012 ·Status: TERMINATED ·Phase: PHASE1
-
A Clinical Trial of Infliximab for Uveitis
NCT00273390 ·Status: COMPLETED ·Phase: NA
-
Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant
NCT04340505 ·Status: COMPLETED
-
Study of Risk Factors for Therapeutic Failure in Chronic Non-Infectious Uveitis After First-Line Immunosuppressive Therapy
NCT06821971 ·Status: ACTIVE_NOT_RECRUITING
-
Phase 2 Study of MM-093 to Treat Patients With Uveitis
NCT00444743 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy
NCT00468871 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Incidence of Macular Edema in a Uveitis Population
NCT06686641 ·Status: ACTIVE_NOT_RECRUITING
-
Use of Thalidomide in Chronic Uveitis
NCT00314665 ·Status: TERMINATED ·Phase: PHASE4
-
Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular Occlusion
NCT05657158 ·Status: COMPLETED
-
The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma
NCT00943982 ·Status: COMPLETED ·Phase: PHASE1